CD28-B7 interactions in T-cell activation

This publication has 33 references indexed in Scilit:

• Tumor escape mechanisms from immunosurveillance: induction of unresponsiveness in a specific MHC-restricted CD4⁺; human T cell clone by the autologous MHC class II⁺ melanoma
  International Immunology, 1993
• A major costimulatory molecule on antigen-presenting cells, CTLA4 ligand A, is distinct from B7.
  The Journal of Experimental Medicine, 1993
• Costimulation of T cells for tumor immunity
  Immunology Today, 1993
• T cell co-stimulation and in vivo tolerance
  Current Opinion in Immunology, 1993
• The Role of the CD28 Receptor During T Cell Responses to Antigen
  Annual Review of Immunology, 1993
• Tumor Rejection After Direct Costimulation of CD8 ⁺ T Cells by B7-Transfected Melanoma Cells
  Science, 1993
• B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cellsin vitro
  European Journal of Immunology, 1993
• Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
  The Journal of Experimental Medicine, 1992
• Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation Molecule
  Science, 1992
• Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg
  Science, 1992